We strongly advocated approval on the basis of the available science, knowing full well that this is no cure. It is a really marginal advantage, but that marginal difference can make a real differenc… [+83 chars]
The road to Aduhelm: What one ex-FDA adviser called probably the worst drug approval decision in recent US history for an Alzheimers treatment – CNN